中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Heterologous expression of lipoprotein-associated phospholipase A(2) in different expression systems

文献类型:期刊论文

作者Zhang, Fujun; Dong, Li; Cai, Maojun; Shen, Jingkang; Wang, Yiping
刊名PROTEIN EXPRESSION AND PURIFICATION
出版日期2006-08
卷号48期号:2页码:300-306
关键词lipoprotein-associated phospholipase A(2) atherosclerosis coronary baculovirus insect cells Pichia pastoris expression purification
ISSN号1046-5928
DOI10.1016/j.pep.2006.03.009
文献子类Article
英文摘要Lipoprotein-associated phospholipase A, (Lp-PLA(2)) is a key enzyme involved in atherosclerosis, and has been considered as a new target for drug discovery. The major difficulty for high-throughput screening of Lp-PLA(2) inhibitors and for functional studies was their fast and efficient production. Purification of native Lp-PLA(2) from human plasma was complicated and produced a very low yield. We herein examined the feasibility of expressing and purifying recombinant Lp-PLA(2) in different heterologous expression systems. The fusion Lp-PLA(2) was expressed at high levels and exhibited strong enzyme activity in insect cell-baculovirus expression system. The functional enzyme could also be produced in Pichia pastoris. The inclusion of a Kozak sequence increased greatly the expression level of recombinant Lp-PLA(2) in insect cells, but had little effect on the expression of recombinant Lp-PLA(2) in P. pastoris and Escherichia coli. P. pastoris-produced Lp-PLA(2) could be purified rapidly and conveniently through a one-step procedure, while baculovirus-produced Lp-PLA(2) could be efficiently purified through a two-step procedure. This ability to readily produce recombinant Lp-PLA(2) could provide a screening model for Lp-PLA(2) inhibitors and will facilitate further studies on this enzyme. (c) 2006 Elsevier Inc. All rights reserved.
WOS关键词ACTIVATING-FACTOR-ACETYLHYDROLASE ; CORONARY-HEART-DISEASE ; ORALLY-ACTIVE INHIBITORS ; C-REACTIVE PROTEIN ; MIDDLE-AGED MEN ; THERAPEUTIC TARGET ; FOLLOW-UP ; RISK ; ATHEROSCLEROSIS ; POTENT
WOS研究方向Biochemistry & Molecular Biology ; Biotechnology & Applied Microbiology
语种英语
WOS记录号WOS:000239696900015
出版者ACADEMIC PRESS INC ELSEVIER SCIENCE
源URL[http://119.78.100.183/handle/2S10ELR8/273532]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Wang, Yiping
作者单位1.Chinese Acad Sci, Shanghai Inst Biol Studies, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Biol Studies, Shanghai Inst Mat Med, Dept Med Chem, Shanghai 201203, Peoples R China
3.Chinese Acad Sci, Grad Sch, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Fujun,Dong, Li,Cai, Maojun,et al. Heterologous expression of lipoprotein-associated phospholipase A(2) in different expression systems[J]. PROTEIN EXPRESSION AND PURIFICATION,2006,48(2):300-306.
APA Zhang, Fujun,Dong, Li,Cai, Maojun,Shen, Jingkang,&Wang, Yiping.(2006).Heterologous expression of lipoprotein-associated phospholipase A(2) in different expression systems.PROTEIN EXPRESSION AND PURIFICATION,48(2),300-306.
MLA Zhang, Fujun,et al."Heterologous expression of lipoprotein-associated phospholipase A(2) in different expression systems".PROTEIN EXPRESSION AND PURIFICATION 48.2(2006):300-306.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。